Table 5. Thirty-day mortality and SAEs until 3 months after treatment or before subsequent treatment.

		TACE (n = 187)	TARE (n = 119)	P
30-day mortality		1 (0.5)	0 (0)	1.00
Hospital stay >7 days after treatment		42 (22.5)	1 (0.8)	<0.01
No. of patients with at least one SAE		50 (26.7)	12 (10.1)	<0.01
	Total no. of SAEs	60	14
	Postembolization syndrome	47	3
	Hepatic encephalopathy	3
	Bacteremia	3
	Acute kidney injury	2
	Urinary tract infection	1
	Myocardial infarction	1
	Jaundice	1
	Liver abscess	1
	Pneumonia		1
	Radiation pneumonitis		4
	Benign biliary stricture		5
	Radioembolization-induced liver disease		1
	Death	1

Data are presented as number of patients (%).

SAE = serious adverse event, TACE = transarterial chemoembolization, TARE = transarterial radioembolization